NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Oxford BioMedica PLC 

Medawar Centre
Robert Robinson Avenue

The Oxford Science Park
Oxford    OX4 4GA  United Kingdom
Phone: 01865-783000 Fax: 01865-783001


SEARCH JOBS




Industry
Services

Segment
Gene Therapy





 Company News
Oxford BioMedica PLC (OXB.L) Says ProSavin Promising; Shares Double 10/15/2009 7:28:21 AM    More...
Oxford BioMedica PLC (OXB.L) Announces Update on Phase I/II Study of ProSavin(R) in Parkinson's Disease 7/13/2009 12:51:33 PM    More...
The Court Supports Bavarian Nordic (BAVA.CO)'s Decision to Start Patent Infringement Case Against Oxford BioMedica PLC (OXB.L) 5/11/2009 7:35:39 AM    More...
Oxford BioMedica PLC (OXB.L) and Sanofi-Aventis (France) (SASY.PA) Enter New Collaboration Worth $50 Million 4/30/2009 7:24:18 AM    More...
Oxford BioMedica PLC (OXB.L): Preliminary Results For The Year Ended 31 December 2008 3/12/2009 12:16:47 PM    More...
Oxford BioMedica PLC (OXB.L) FY Revenue Up to 18.4 Million Stage 3/12/2009 7:59:32 AM    More...
Oxford BioMedica PLC (OXB.L) Receives Further Investment Under Agreement Led by the Foundation Fighting Blindness 2/5/2009 1:58:21 PM    More...
Bavarian Nordic (BAVA.CO)'s Case Against Oxford BioMedica PLC (OXB.L) 1/12/2009 9:49:19 AM    More...
Oxford BioMedica PLC (OXB.L) Announces Six-Month Efficacy Results With Low Dose of ProSavin(R) in Phase I/II Trial in Parkinson’s Disease 11/19/2008 12:05:20 PM    More...
Oxford BioMedica PLC (OXB.L) Announces Two Scientific Presentations of ProSavin in Parkinson's Disease 11/14/2008 12:45:11 PM    More...
12345678910